CleanSpace Holdings Ltd (ASX: CSX) Share Price and News

Mr Rathie is an experienced company director having completed prior careers in law and investment banking. He practised as a partner in a large legal firm and acted as Senior Corporate Counsel to Bell Resources Limited in the early to mid-1980s. He studied for his MBA in Geneva and embarked on his investment banking career on his return to Sydney. Mr Rathie was Head of the Industrial Franchise Group at Salomon Smith Barney in the late 1990s and led Salomons roles in the Federal Government's privatisations of Qantas, Commonwealth Bank and Telstra. He has over 20 years' experience as a professional non-executive company director.In the medical device space, Mr Rathie was previously Chairman of Anteo Diagnostics Limited and a Director of Compumedics Limited and USCOM Limited.He is member of Risk Committee.

Mr Kao,founded the business of CleanSpace in 2009 and has been a director of CleanSpace since April 2011. Mr Kao worked in the medical and healthcare industry for over 20 years, and has experience in manufacturing, supply chain optimisation, quality management systems and in securing patents for innovative technologies in healthcare.

Ms Hennessy is an American born Harvard Business School graduate and a highly experienced executive and company director with over 30 years of experience worldwide. Lisa has built an impressive career in Australia including her role as a successful angel investor and has extensive non-executive director experience across listed and private organisations. and sits on the boards of Aikenhead Centre for Medical Discovery (ACMD), and the Harvard Club of Victoria.Walter and Eliza Hall Institute of Medical Research Commercialisation Committee, Planet Innovation, FirstStep Investments and Arts Centre Melbourne Foundation. Prior to this, Lisa spent over a decade in strategy and M&A roles in the US, including Director of Strategy and M&A for Del Monte Foods, Director of M&A at GE Capital, and was also a Consultant at Bain & Company.She is Chairman of Risk committee.

Mr McLean has financial and commercial experience within the medical technology sector. He also has an understanding of North America and UK listed entities having worked in finance and operations roles for international companies. Mr McLean worked with NYSE-listed Stryker for 16 years and has medical device and healthcare experience. At Stryker, Mr McLean held several senior positions including as president for Japan, Australia/ New Zealand and Asia Pacific when he was based in Singapore and Hong Kong. Mr McLean was also responsible for transforming Asia Pacific including restructuring their China distribution. Prior to Stryker, he held senior finance and operation roles in Asia and Europe including international consumer brands Lion Nathan, Smiths Snackfoods (Pepsi), McVities (United Biscuits), United Distillers (Guinness) and Unilever. an advisor to Bain & Company and GLG and a board member of Suicide Prevention Australia.Mr McLean is member of Risk Management Committee.

Mr Cassano is an executive with over 30 years industry experience in general management, operations management and technical roles in the mining and resources sectors with Downer, Thiess and BHP. Pauls experience includes 13 years at Downer, where he was most recently CEO Mining, 14 years at BHP in leadership and technical roles, and as EGM, Resources and Development Group at Thiess. Paul currently provides independent management consulting services as Managing Director of Resilient Resources Pty Ltd.

-

-

-